Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

4.00
Delayed Data
As of Feb 24
 +0.15 / +3.90%
Today’s Change
2.65
Today|||52-Week Range
7.60
+31.15%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close3.85
Today’s open3.75
Day’s range3.75 - 4.05
Volume644,689
Average volume (3 months)845,859
Market cap$282.5M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-48.72%
Earnings growth (this year)-95.44%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-13.80%
P/E ratioNM
Price/Sales16.11
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...0.000.00%
RIGLRigel Pharmaceutical...-0.02-0.86%
EDGEEdge Therapeutics In...+0.09+0.90%
KMDAKamada Ltd+0.10+1.34%
Data as of 4:00pm ET, 02/24/2017

Financials

Last reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$39.5M
Annual profit (last year)-$40.7M
Net profit margin-102.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Executive Vice President
Henry Ward Wolff
Corporate headquarters
Richmond, California

Forecasts


Search for Jobs